1,038 results on '"Braat, D.D.M."'
Search Results
2. Web-based Guidance for Assisted Reproductive Technology With an Online App (myFertiCare): Quantitative Evaluation With the HOT-fit Framework.
- Author
-
Sparidaens, E.M., Logger, J.G.M., Nelen, W.L.D.M., Braat, D.D.M., Fleischer, K., Hermens, R.P., Sparidaens, E.M., Logger, J.G.M., Nelen, W.L.D.M., Braat, D.D.M., Fleischer, K., and Hermens, R.P.
- Abstract
Contains fulltext : 291076.pdf (Publisher’s version ) (Open Access), BACKGROUND: Assisted reproductive technologies (ARTs) are considered to be physically and mentally stressful. During their treatment trajectory, couples express high information and communication needs. They appreciate using the internet to obtain fertility-related information. In a previous study, we developed myFertiCare, an eHealth tool providing personalized information and interactive functionalities for infertile couples in order to improve patient-centered care. The app has already been successful in qualitative evaluations of usability. OBJECTIVE: The aim of the current study is to quantitatively evaluate the implementation of myFertiCare by using the human, organizational, and technology-fit (HOT-fit) framework and to study the effects of using myFertiCare on couples' knowledge about infertility, their experience of the burden of infertility, and their experience of patient-centered care. With these results, implementation can be further improved, and patient-centered care can be enhanced. METHODS: A quantitative study was performed based on the HOT-fit framework using validated questionnaires focusing on the human, organizational, and technology domains. Questions were added on the effect of using myFertiCare on couples' knowledge about infertility and treatment. Questions regarding the burden of infertility, the burden of infertility treatment, and the experience of patient-centeredness were based on the main items of the validated fertility quality of life (FertiQoL) and Patient-Centredness Questionnaire-Infertility questionnaires, respectively. Also, nonusers of the app were included to explore motivations for not using the app and identify opportunities for improvement. Finally, user data were analyzed to provide insight into multiple variables concerning app use. RESULTS: In the human and technology domains, myFertiCare showed good system usability, high user satisfaction, and high information and interface quality. In the organizational domain, imple
- Published
- 2023
3. Quality of integrated female oncofertility care is suboptimal: A patient-reported measurement.
- Author
-
Berg, M. van den, Kaal, S.E.J., Schuurman, T.N., Braat, D.D.M., Mandigers, C.M.P.W., Tol, J van, Tromp, J.M., Vorst, M.J.D.L. van der, Beerendonk, C.C.M., Hermens, R.P.M.G., Berg, M. van den, Kaal, S.E.J., Schuurman, T.N., Braat, D.D.M., Mandigers, C.M.P.W., Tol, J van, Tromp, J.M., Vorst, M.J.D.L. van der, Beerendonk, C.C.M., and Hermens, R.P.M.G.
- Abstract
01 februari 2023, Item does not contain fulltext, BACKGROUND: Clinical practice guidelines recommend to inform female cancer patients about their infertility risks due to cancer treatment. Unfortunately, it seems that guideline adherence is suboptimal. In order to improve quality of integrated female oncofertility care, a systematic assessment of current practice is necessary. METHODS: A multicenter cross-sectional survey study in which a set of systematically developed quality indicators was processed, was conducted among female cancer patients (diagnosed in 2016/2017). These indicators represented all domains in oncofertility care; risk communication, referral, counseling, and decision-making. Indicator scores were calculated, and determinants were assessed by multilevel multivariate analyses. RESULTS: One hundred twenty-one out of 344 female cancer patients participated. Eight out of 11 indicators scored below 90% adherence. Of all patients, 72.7% was informed about their infertility, 51.2% was offered a referral, with 18.8% all aspects were discussed in counseling, and 35.5% received written and/or digital information. Patient's age, strength of wish to conceive, time before cancer treatment, and type of healthcare provider significantly influenced the scores of three indicators. CONCLUSIONS: Current quality of female oncofertility care is far from optimal. Therefore, improvement is needed. To achieve this, improvement strategies that are tailored to the identified determinants and to guideline-specific barriers should be developed.
- Published
- 2023
4. Towards Patient-Centered Pain Relief During Oocyte Retrieval for IVF and ICSI
- Author
-
Braat, D.D.M., Steeg, J.W. van der, Huppelschoten, A.G., Buisman, E.T.I.A., Braat, D.D.M., Steeg, J.W. van der, Huppelschoten, A.G., and Buisman, E.T.I.A.
- Abstract
Radboud University, 30 januari 2023, Promotor : Braat, D.D.M. Co-promotores : Steeg, J.W. van der, Huppelschoten, A.G., Contains fulltext : 286407.pdf (Publisher’s version ) (Closed access)
- Published
- 2023
5. Improving patient-centered information provision in fertility care
- Author
-
Braat, D.D.M., Hermens, R.P.M.G., Fleischer, K., Beerendonk, C.C.M., Sparidaens, E.M., Braat, D.D.M., Hermens, R.P.M.G., Fleischer, K., Beerendonk, C.C.M., and Sparidaens, E.M.
- Abstract
Radboud University, 25 januari 2023, Promotores : Braat, D.D.M., Hermens, R.P.M.G. Co-promotores : Fleischer, K., Beerendonk, C.C.M., Contains fulltext : 286404.pdf (Publisher’s version ) (Open Access)
- Published
- 2023
6. The lack of evidence behind over-the-counter antioxidant supplements for male fertility patients: a scoping review.
- Author
-
Ligny, W.R. de, Fleischer, K., Grens, H., Braat, D.D.M., Bruin, J.P. de, Ligny, W.R. de, Fleischer, K., Grens, H., Braat, D.D.M., and Bruin, J.P. de
- Abstract
Item does not contain fulltext, STUDY QUESTION: What is the evidence for over-the-counter antioxidant supplements for male infertility? SUMMARY ANSWER: Less than half of over-the-counter antioxidant supplements for male fertility patients have been tested in a clinical trial, and the available clinical trials are generally of poor quality. WHAT IS KNOWN ALREADY: The prevalence of male infertility is rising and, with this, the market for supplements claiming to improve male fertility is expanding. Up to now, there is limited data on the evidence for these over-the-counter supplements. STUDY DESIGN SIZE DURATION: Amazon, Google Shopping and other relevant shopping websites were searched on 24 June 2022 with the following terms: 'supplements', 'antioxidants', 'vitamins', AND 'male fertility', 'male infertility', 'male subfertility', 'fertility men', 'fertility man'. All supplements with a description of ingredients in English, Dutch, French, Spanish, or German were included. Subsequently, Pubmed and Google Scholar were searched for studies that included the supplements. PARTICIPANTS/MATERIALS SETTING METHODS: Inclusion criteria were supplements with antioxidant properties, of which the main purpose was to improve male fertility. Included supplements must be available without a doctor's prescription. Supplements containing plant extracts were excluded, as well as supplements of which the content or dosage was not clear. The ingredients, dosage, price and health claims of the supplements were recorded. We assessed whether substances in the supplements exceeded the recommended dietary allowance (RDA) or tolerable upper intake level (UL). All clinical trials and animal studies investigating included supplements were selected for this review. Clinical trials were assessed for risk of bias with a risk of bias tool appropriate for the study design. MAIN RESULTS AND THE ROLE OF CHANCE: There were 34 eligible antioxidant supplements found, containing 48 different active substances. The average price per 30 da
- Published
- 2023
7. Deciding on future fertility: considerations of girls with Turner syndrome and their parents to opt for or against ovarian tissue cryopreservation.
- Author
-
Nadesapillai, S., Coelen, S. van der, Goebel, L., Peek, R., Braat, D.D.M., Velden, J.A. van der, Fleischer, K., Oerlemans, A.J.M., Nadesapillai, S., Coelen, S. van der, Goebel, L., Peek, R., Braat, D.D.M., Velden, J.A. van der, Fleischer, K., and Oerlemans, A.J.M.
- Abstract
01 juni 2023, Item does not contain fulltext, RESEARCH QUESTION: What are the considerations of girls with Turner syndrome and their parents to opt for or against ovarian tissue cryopreservation (OTC)? DESIGN: Semi-structured in-depth interviews were conducted with girls with Turner syndrome and their parents until data saturation was reached. Participants were recruited through purposive sampling. Data were analysed using a thematic analysis approach. RESULTS: Thirteen parents and five girls who opted for OTC, and seven parents and three girls who declined OTC, were interviewed. Parents and girls mentioned that OTC offered hope, an opportunity to have genetic offspring and clarity about their current fertility status. Most participants were not afraid of the risks of surgery and trusted healthcare providers with this procedure. In contrast, families had to deal with uncertainties, owing to the lack of information on the success rate and long-term consequences of OTC in this group. Families indicated that they had to go through an important decision-making process in a short period of time, because of the limited number of participants in the OTC study. CONCLUSION: A new opportunity and hope for future fertility were considerations for opting for OTC. However, OTC also came with uncertainties owing to the experimental nature of this procedure in girls with Turner syndrome. Healthcare providers could share these experiences with girls with Turner syndrome and their parents to improve fertility-preservation counselling in this group.
- Published
- 2023
8. Exploring X Chromosomal Aberrations in Ovarian Cells by using Fluorescence In Situ Hybridization.
- Author
-
Nadesapillai, S., Velden, J.A. van der, Braat, D.D.M., Fleischer, K., Peek, R., Nadesapillai, S., Velden, J.A. van der, Braat, D.D.M., Fleischer, K., and Peek, R.
- Abstract
Item does not contain fulltext, Millions of people worldwide deal with issues concerning fertility. Reduced fertility, or even infertility, may be due to many different causes, including genetic disorders, of which chromosomal abnormalities are the most common. Fluorescence in situ hybridization (FISH) is a well-known and frequently used method to detect chromosomal aberrations in humans. FISH is mainly used for the analysis of chromosomal abnormalities in the spermatozoa of males with numerical or structural chromosomal aberrations. Furthermore, this technique is also frequently applied in females to detect X chromosomal aberrations that are known to cause ovarian dysgenesis. However, information on the X chromosomal content of ovarian cells from females with X chromosomal aberrations in lymphocytes and/or buccal cells is still lacking. The aim of this study is to advance basic research regarding X chromosomal aberrations in females, by presenting two methods based on FISH to identify the X chromosomal content of ovarian cells. First, a method is described to determine the X chromosomal content of isolated ovarian cells (oocytes, granulosa cells, and stromal cells) in non-grafted ovarian cortex tissue from females with X chromosomal aberrations. The second method is directed at evaluating the effect of chromosomal aberrations on folliculogenesis by determining the X chromosomal content of ovarian cells of newly formed secondary and antral follicles in ovarian tissue, from females with X chromosomal aberrations after long-term grafting into immunocompromised mice. Both methods could be helpful in future research to gain insight into the reproductive potential of females with X chromosomal aberrations.
- Published
- 2023
9. Assessment of folliculogenesis in ovarian tissue from young patients with Turner syndrome using a murine xenograft model.
- Author
-
Peek, R., Nadesapillai, S., Nguyen, T.Y.T., Vassart, Sarah, Smeets, D.F.C.M., Zande, G. van de, Camboni, A., Braat, D.D.M., Velden, J.A. van der, Donnez, J., Fleischer, K., Dolmans, M.M., Peek, R., Nadesapillai, S., Nguyen, T.Y.T., Vassart, Sarah, Smeets, D.F.C.M., Zande, G. van de, Camboni, A., Braat, D.D.M., Velden, J.A. van der, Donnez, J., Fleischer, K., and Dolmans, M.M.
- Abstract
01 augustus 2023, Item does not contain fulltext, OBJECTIVE: To study the impact of aneuploid granulosa and stromal cells on folliculogenesis of small ovarian follicles from patients with mosaic Turner syndrome (TS) using a murine xenograft model. DESIGN: Laboratory study. SETTING: University hospital. PATIENT(S): Ovarian cortical tissue was obtained by laparoscopic surgery from 18 patients with mosaic TS (aged 5-19 years) and 13 controls (aged 5-18 years). INTERVENTION(S): Part of each tissue fragment was used to karyotype ovarian cells in nongrafted tissue by fluorescence in situ hybridization. The remaining tissue was xenografted to severe combined immunodeficient mice for 5 months. Grafted tissue was analyzed for aneuploidy, and follicle density and morphology were determined. Expressions of proliferating cell nuclear antigen and anti-Müllerian hormone were investigated by immunohistochemistry. MAIN OUTCOME MEASURE(S): The impact of aneuploid granulosa and stromal cells on folliculogenesis. Fluorescence in situ hybridization of ovarian tissue before grafting was performed to determine the level of aneuploidy in stromal cells and oocytes and granulosa of small follicles. After xenografting, the level of aneuploidy of the newly formed layers of granulosa cells was again determined in secondary and antral follicles. RESULT(S): Follicle density in ovarian tissue from patients with TS was significantly lower than in controls before grafting. Fluorescence in situ hybridization analysis confirmed that 101 of 104 oocytes from nongrafted tissue of patients with TS showed normal X chromosome content, whereas granulosa and stromal cells were mainly 45,X. Fragments from 12 patients with TS contained follicles at all stages after xenografting, including secondary and antral follicles. Follicle density in patients with TS and controls decreased significantly after grafting. Moreover, a shift from high to low proportions of 45,X granulosa cells was observed during folliculogenesis. Expression of proliferating cell nuclear ant
- Published
- 2023
10. Is it fun or is it hard? Studying physician-related attributes of shared decision-making by ranking case vignettes
- Author
-
Spinnewijn, L., Aarts, J.W.M., Braat, D.D.M., Baranov, N.S., Sijtsma, K., Ellis, J.L., Scheele, F., Spinnewijn, L., Aarts, J.W.M., Braat, D.D.M., Baranov, N.S., Sijtsma, K., Ellis, J.L., and Scheele, F.
- Abstract
Contains fulltext : 296766.pdf (Publisher’s version ) (Open Access), OBJECTIVE: This study investigated provider-related attributes of shared decision-making (SDM). It studied how physicians rank SDM cases compared to other cases, taking 'job satisfaction' and 'complexity' as ranking criteria. METHODS: Ten vignettes representing three cases of SDM, three cases dealing with patients' emotions and four with technical problems were designed to conduct a modified ordinal preference elicitation study. Gynaecologists and trainees ranked the vignettes for 'job satisfaction' or 'complexity'. Results were analysed by comparing the top three and down three ranked cases for each type of case using exact p-values obtained with custom-made randomisation tests. RESULTS: Participants experienced more satisfaction significantly from performing technical cases than cases dealing with emotions or SDM. Moreover, technical cases were perceived as less complex than those dealing with emotions. However, results were inconclusive about whether gynaecologists find SDM complex. CONCLUSION: Findings suggest gynaecologists experience lower satisfaction with SDM tasks, possibly due to them falling outside their comfort zone. Integrating SDM into daily routines and promoting culture change favouring dealing with non-technical problems might help mitigate issues in SDM implementation. INNOVATION: Our novel study assesses SDM in the context of task appraisal, illuminating the psychology of health professionals and providing valuable insights for implementation science.
- Published
- 2023
11. TurnerFertility trial: fertility preservation in young girls with Turner syndrome by freezing ovarian cortex tissue-a prospective intervention study
- Author
-
Nadesapillai, S., Velden, A.A.E.M. van der, Coelen, S. van der, Schleedoorn, M.J., Sedney, Amy, Spath, M.A., Schurink, M., Oerlemans, A.J.M., Hout, J. in 't, Beerendonk, C.C.M., Braat, D.D.M., Peek, R., Fleischer, Kathrin, Nadesapillai, S., Velden, A.A.E.M. van der, Coelen, S. van der, Schleedoorn, M.J., Sedney, Amy, Spath, M.A., Schurink, M., Oerlemans, A.J.M., Hout, J. in 't, Beerendonk, C.C.M., Braat, D.D.M., Peek, R., and Fleischer, Kathrin
- Abstract
Item does not contain fulltext
- Published
- 2023
12. Reproductive Outcomes of Women with Turner Syndrome Undergoing Oocyte Vitrification: A Retrospective Multicenter Cohort Study
- Author
-
Nadesapillai, S., Mol, Femke, Broer, Simone L., Stevens Brentjens, Linda B.P.M., Verhoeven, Marieke O., Heida, Karst Y., Coelen, Sanne van der, Peek, Ronald, Braat, D.D.M., Velden, A.A.E.M. van der, Fleischer, Kathrin, Nisolle, Michelle, Nadesapillai, S., Mol, Femke, Broer, Simone L., Stevens Brentjens, Linda B.P.M., Verhoeven, Marieke O., Heida, Karst Y., Coelen, Sanne van der, Peek, Ronald, Braat, D.D.M., Velden, A.A.E.M. van der, Fleischer, Kathrin, and Nisolle, Michelle
- Abstract
Item does not contain fulltext
- Published
- 2023
13. Risk of Colorectal Cancer After Ovarian Stimulation for In Vitro Fertilization
- Author
-
Schats, R., Lambalk, C.B., Kortman, M., Laven, J.S.E., Jansen, C.A.M., van der Westerlaken, L.A.J., Cohlen, B.J., Braat, D.D.M., Smeenk, J.M.J., Land, J.A., van der Veen, F., Evers, J.L.H., van Rumste, M.M.E., Spaan, Mandy, van den Belt-Dusebout, Alexandra W., Burger, Curt W., and van Leeuwen, Flora E.
- Published
- 2016
- Full Text
- View/download PDF
14. External quality control and training of semen analysis in the Netherlands: starting point for further reduction of outcome variability
- Author
-
Lemmens, L., Hoven, Leonie van den, Vrouwerff, Netty J. van, Braat, D.D.M., Nelen, W.L.D.M., Spath, M.A., Wetzels, A.M.M., Lemmens, L., Hoven, Leonie van den, Vrouwerff, Netty J. van, Braat, D.D.M., Nelen, W.L.D.M., Spath, M.A., and Wetzels, A.M.M.
- Abstract
Item does not contain fulltext
- Published
- 2022
15. Towards implementation of high-quality female oncofertility care
- Author
-
Braat, D.D.M., Hermens, R.P.M.G., Berendonk, C., Berg, M. van den, Braat, D.D.M., Hermens, R.P.M.G., Berendonk, C., and Berg, M. van den
- Abstract
Radboud University, 13 mei 2022, Promotor : Braat, D.D.M. Co-promotores : Hermens, R.P.M.G., Berendonk, C., Contains fulltext : 249040.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
16. A de novo paradigm for male infertility
- Author
-
Oud, M.S., Smits, R.M., Smith, H.E., Mastrorosa, F.K., Holt, G.S., Houston, B.J., Vries, P.F. de, Alobaidi, B.K.S., Batty, L.E., Ismail, H., Greenwood, J., Sheth, H., Mikulasova, A., Astuti, G.D.N, Gilissen, C., McEleny, K., Turner, H., Coxhead, J., Cockell, S., Braat, D.D.M., Fleischer, K., D'Hauwers, K.W.M., Schaafsma, E., Nagirnaja, L., Conrad, D.F., Friedrich, C., Kliesch, S., Aston, K.I., Riera-Escamilla, A., Krausz, C., Gonzaga-Jauregui, C., Santibanez-Koref, M., Elliott, D.J., Vissers, L.E.L.M., Tüttelmann, F., O'Bryan, M.K., Ramos, L., Xavier, M.J., Heijden, G.W. van der, Veltman, J.A., Oud, M.S., Smits, R.M., Smith, H.E., Mastrorosa, F.K., Holt, G.S., Houston, B.J., Vries, P.F. de, Alobaidi, B.K.S., Batty, L.E., Ismail, H., Greenwood, J., Sheth, H., Mikulasova, A., Astuti, G.D.N, Gilissen, C., McEleny, K., Turner, H., Coxhead, J., Cockell, S., Braat, D.D.M., Fleischer, K., D'Hauwers, K.W.M., Schaafsma, E., Nagirnaja, L., Conrad, D.F., Friedrich, C., Kliesch, S., Aston, K.I., Riera-Escamilla, A., Krausz, C., Gonzaga-Jauregui, C., Santibanez-Koref, M., Elliott, D.J., Vissers, L.E.L.M., Tüttelmann, F., O'Bryan, M.K., Ramos, L., Xavier, M.J., Heijden, G.W. van der, and Veltman, J.A.
- Abstract
Item does not contain fulltext, De novo mutations are known to play a prominent role in sporadic disorders with reduced fitness. We hypothesize that de novo mutations play an important role in severe male infertility and explain a portion of the genetic causes of this understudied disorder. To test this hypothesis, we utilize trio-based exome sequencing in a cohort of 185 infertile males and their unaffected parents. Following a systematic analysis, 29 of 145 rare (MAF < 0.1%) protein-altering de novo mutations are classified as possibly causative of the male infertility phenotype. We observed a significant enrichment of loss-of-function de novo mutations in loss-of-function-intolerant genes (p-value = 1.00 × 10(-5)) in infertile men compared to controls. Additionally, we detected a significant increase in predicted pathogenic de novo missense mutations affecting missense-intolerant genes (p-value = 5.01 × 10(-4)) in contrast to predicted benign de novo mutations. One gene we identify, RBM5, is an essential regulator of male germ cell pre-mRNA splicing and has been previously implicated in male infertility in mice. In a follow-up study, 6 rare pathogenic missense mutations affecting this gene are observed in a cohort of 2,506 infertile patients, whilst we find no such mutations in a cohort of 5,784 fertile men (p-value = 0.03). Our results provide evidence for the role of de novo mutations in severe male infertility and point to new candidate genes affecting fertility.
- Published
- 2022
17. Trends in research on pain relief during oocyte retrieval for IVF/ICSI: a systematic, methodological review
- Author
-
Buisman, E.T.I.A., Grens, H, Wang, R., Bhattacharya, S., Braat, D.D.M., Huppelschoten, A.G., Steeg, J.W. van der, Buisman, E.T.I.A., Grens, H, Wang, R., Bhattacharya, S., Braat, D.D.M., Huppelschoten, A.G., and Steeg, J.W. van der
- Abstract
Item does not contain fulltext, STUDY QUESTION: What is the methodological validity and usefulness of randomized controlled trials (RCTs) on pain relief during oocyte retrieval for IVF and ICSI? SUMMARY ANSWER: Key methodological characteristics such as randomization, allocation concealment, primary outcome measure and sample size calculation were inadequately reported in 33-43% of the included RCTs, and a broad heterogeneity is revealed in the studied outcome measures. WHAT IS KNOWN ALREADY: A Cochrane review on conscious sedation and analgesia for women undergoing oocyte retrieval concluded that the overall quality of evidence was low or very low, mainly owing to poor reporting. This, and heterogeneity of studied outcome measures, limits generalizability and eligibility of results for meta-analysis. STUDY DESIGN SIZE DURATION: For this review, a systematic search for RCTs on pain relief during oocyte retrieval was performed on 20 July 2020 in CENTRAL CRSO, MEDLINE, Embase, PsycINFO, CINAHL, ClinicalTrials.gov, WHO ICTRP, Web of Science, Portal Regional da BVS and Open Grey. PARTICIPANTS/MATERIALS SETTING METHODS: RCTs with pain or patient satisfaction as an outcome were included and analysed on a set of methodological and clinical characteristics, to determine their validity and usefulness. MAIN RESULTS AND THE ROLE OF CHANCE: Screening of 2531 articles led to an inclusion of 51 RCTs. Randomization was described inadequately in 33% of the RCTs. A low-risk method of allocation concealment was reported in 55% of the RCTs. Forty-nine percent of the RCTs reported blinding of participants, 33% of blinding personnel and 43% of blinding the outcome assessor. In 63% of the RCTs, the primary outcome was stated, but a sample size calculation was described in only 57%. Data were analysed according to the intention-to-treat principle in 73%. Treatment groups were not treated identically other than the intervention of interest in 10% of the RCTs. The primary outcome was intraoperative pain in 28%, and postop
- Published
- 2022
18. Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.
- Author
-
Hamel, C.C., Snijders, M.P.M.L., Coppus, S.F., Vandenbussche, F.P.H.A., Braat, D.D.M., Adang, E.M., Hamel, C.C., Snijders, M.P.M.L., Coppus, S.F., Vandenbussche, F.P.H.A., Braat, D.D.M., and Adang, E.M.
- Abstract
Item does not contain fulltext
- Published
- 2022
19. Structurally collecting patient feedback on trainee skills: A pilot study in Obstetrics and Gynaecology
- Author
-
Spinnewijn, L., Bolte, A.C., Braat, D.D.M., Scheele, F., Aarts, J.W.M., Spinnewijn, L., Bolte, A.C., Braat, D.D.M., Scheele, F., and Aarts, J.W.M.
- Abstract
Item does not contain fulltext, OBJECTIVE: This pilot study tested a tool that collects patient feedback on trainees' skills in shared decision-making (SDM) and general consultation. It also examined trainees' views on SDM and patient feedback, exploring potential skills improvement through reflexive practice. METHODS: Patients were asked to rate trainees after consultation in a six-itemed questionnaire. The questionnaire included 'CollaboRATE' (a validated tool to test SDM), the 'Net Promoter Score' and two open-ended questions. Questionnaire results were described quantitatively and tested for differences. Results were presented to trainees at three intervals. Trainees were interviewed afterwards. Interview transcripts were thematically analysed. RESULTS: Eleven trainees in Obstetrics and Gynaecology participated. Out of 1651 sent questionnaires 399 were returned (response rate 24%). Questionnaire results showed no differences when comparing trainees or group scores over time. Interview results were thematically analysed using the reflexivity framework. Trainees were able to reflect on their SDM skills. They valued receiving patient feedback, yet were able to formulate few learning points from it. CONCLUSION: Although skills improvement was not evident, patient feedback still has potential benefits. PRACTICE IMPLICATIONS: Patient feedback should be combined with facilitated reflections at timely intervals to reinforce behaviour change. Supervisors play an important role in facilitating reflections with trainees.
- Published
- 2022
20. Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model
- Author
-
Hamel, C.C., Vart, P., Vandenbussche, F.P., Braat, D.D.M., Snijders, M., Coppus, S.F., Hamel, C.C., Vart, P., Vandenbussche, F.P., Braat, D.D.M., Snijders, M., and Coppus, S.F.
- Abstract
Item does not contain fulltext, STUDY QUESTION: What are clinical predictors for successful medical treatment in case of early pregnancy loss (EPL)? SUMMARY ANSWER: Use of mifepristone, BMI, number of previous uterine aspirations and the presence of minor clinical symptoms (slight vaginal bleeding or some abdominal cramps) at treatment start are predictors for successful medical treatment in case of EPL. WHAT IS KNOWN ALREADY: Success rates of medical treatment for EPL vary strongly, between but also within different treatment regimens. Up until now, although some predictors have been identified, no clinical prediction model has been developed yet. STUDY DESIGN, SIZE, DURATION: Secondary analysis of a multicentre randomized controlled trial in 17 Dutch hospitals, executed between 28 June 2018 and 8 January 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with a non-viable pregnancy between 6 and 14 weeks of gestational age, who opted for medical treatment after a minimum of 1 week of unsuccessful expectant management. Potential predictors for successful medical treatment of EPL were chosen based on literature and expert opinions. We internally validated the prediction model using bootstrapping techniques. MAIN RESULTS AND THE ROLE OF CHANCE: 237 out of 344 women had a successful medical EPL treatment (68.9%). The model includes the following variables: use of mifepristone, BMI, number of previous uterine aspirations and the presence of minor clinical symptoms (slight vaginal bleeding or some abdominal cramps) at treatment start. The model shows a moderate capacity to discriminate between success and failure of treatment, with an AUC of 67.6% (95% CI = 64.9-70.3%). The model had a good fit comparing predicted to observed probabilities of success but might underestimate treatment success in women with a predicted probability of success of ∼70%. LIMITATIONS, REASONS FOR CAUTION: The vast majority (90.4%) of women were Caucasian, potentially leading to less optimal model performance in a non-Cauc
- Published
- 2022
21. De novo mutations in children born after medical assisted reproduction
- Author
-
Smits, R.M., Xavier, M.J., Oud, M.S., Astuti, G.D.N, Meijerink, A.M., Vries, P.F. de, Holt, G.S., Alobaidi, B.K.S., Batty, L.E., Khazeeva, G., Sablauskas, K., Vissers, L.E.L.M., Gilissen, C., Fleischer, K., Braat, D.D.M., Ramos, L., Veltman, J.A., Smits, R.M., Xavier, M.J., Oud, M.S., Astuti, G.D.N, Meijerink, A.M., Vries, P.F. de, Holt, G.S., Alobaidi, B.K.S., Batty, L.E., Khazeeva, G., Sablauskas, K., Vissers, L.E.L.M., Gilissen, C., Fleischer, K., Braat, D.D.M., Ramos, L., and Veltman, J.A.
- Abstract
Contains fulltext : 251982.pdf (Publisher’s version ) (Open Access), STUDY QUESTION: Are there more de novo mutations (DNMs) present in the genomes of children born through medical assisted reproduction (MAR) compared to spontaneously conceived children? SUMMARY ANSWER: In this pilot study, no statistically significant difference was observed in the number of DNMs observed in the genomes of MAR children versus spontaneously conceived children. WHAT IS KNOWN ALREADY: DNMs are known to play a major role in sporadic disorders with reduced fitness such as severe developmental disorders, including intellectual disability and epilepsy. Advanced paternal age is known to place offspring at increased disease risk, amongst others by increasing the number of DNMs in their genome. There are very few studies reporting on the effect of MAR on the number of DNMs in the offspring, especially when male infertility is known to be affecting the potential fathers. With delayed parenthood an ongoing epidemiological trend in the 21st century, there are more children born from fathers of advanced age and more children born through MAR every day. STUDY DESIGN, SIZE, DURATION: This observational pilot study was conducted from January 2015 to March 2019 in the tertiary care centre at Radboud University Medical Center. We included a total of 53 children and their respective parents, forming 49 trios (mother, father and child) and two quartets (mother, father and two siblings). One group of children was born after spontaneous conception (n = 18); a second group of children born after IVF (n = 17) and a third group of children born after ICSI combined with testicular sperm extraction (ICSI-TESE) (n = 18). In this pilot study, we also subdivided each group by paternal age, resulting in a subgroup of children born to younger fathers (<35 years of age at conception) and older fathers (>45 years of age at conception). PARTICIPANTS/MATERIALS, SETTING, METHODS: Whole-genome sequencing (WGS) was performed on all parent-offspring trios to identify DNMs. For 34 of 53 tri
- Published
- 2022
22. The Decision-Making Process regarding Ovarian Tissue Cryopreservation in Girls with Turner Syndrome by Patients, Parents, and Healthcare Providers: A Mixed-Methods Study
- Author
-
Coelen, S. van der, Velden, J.A. van der, Nadesapillai, S., Peek, R., Braat, D.D.M., Schleedoorn, M.J., Fleischer, K., Oerlemans, A.J.M., Coelen, S. van der, Velden, J.A. van der, Nadesapillai, S., Peek, R., Braat, D.D.M., Schleedoorn, M.J., Fleischer, K., and Oerlemans, A.J.M.
- Abstract
Contains fulltext : 282940.pdf (Publisher’s version ) (Open Access), INTRODUCTION: Ovarian tissue cryopreservation (OTC) has proven to be effective in other patient groups, but the effectiveness in girls with Turner syndrome (TS) is still unclear. Guidelines for counselling about OTC in TS are lacking. The aim of this study was to gain insight into the experiences of patients, parents, and healthcare providers with the decision-making process regarding OTC in girls with TS. METHODS: Within a year after counselling, a survey was sent to 132 girls with TS and their parents. Furthermore, focus groups were conducted with (1) gynaecologists with subspeciality reproductive medicine, (2) paediatric endocrinologists, (3) parents of girls aged 2-12, and (4) parents of girls aged 13-18. Transcripts were analysed using a thematic analysis approach. RESULTS: The response rate of the survey was 45%. Of the survey respondents, 90% appreciated counselling regarding their future parenting options and considered it an addition to existing healthcare. Girls with TS and their parents indicated that the option of OTC raised hope for future genetic offspring and instantly made them feel that their only option was to seize this opportunity. Gynaecologists and paediatricians found it challenging to truly make families grasp a realistic perspective of OTC in girls with TS. DISCUSSION AND CONCLUSION: Offering young girls with TS the possibility of fertility preservation in an experimental setting raised high hopes and led to challenges for healthcare providers in ensuring a considered decision. The appropriate moment for counselling should be tailored to the individual and discussed with patient, parents, and paediatrician.
- Published
- 2022
23. Strategies to safely use cryopreserved ovarian tissue to restore fertility after cancer: a systematic review
- Author
-
Eijkenboom, L.L., Saedt, Emma, Zietse, C., Braat, D.D.M., Beerendonk, C.C.M., Peek, R., Eijkenboom, L.L., Saedt, Emma, Zietse, C., Braat, D.D.M., Beerendonk, C.C.M., and Peek, R.
- Abstract
Contains fulltext : 282973.pdf (Publisher’s version ) (Open Access), Ovarian tissue cryopreservation and subsequent autotransplantation is a successful technique for fertility preservation in oncological patients. However, there are concerns regarding safety, as the graft may contain malignant cells that could lead to the reintroduction of cancer. To circumvent this problem several experimental strategies are being pursued. This systematic review was conducted to provide an overview of the strategies aiming to safely use cryopreserved human ovarian tissue to restore fertility after cancer. Thirty-one studies were included, covering five different experimental strategies: (i) in-vitro maturation of oocytes, (ii) constructing an artificial ovary as a scaffold for reseeding pre-antral follicles, (iii) purging strategies aimed at the eradication of contaminating malignant cells, (iv) maturation of oocytes by xenotransplantation, and (v) stem cell-based oogenesis. These strategies to circumvent the reintroduction of cancer cells through ovarian tissue autotransplantation are being developed, but so far have not reached the stage of clinical trials. Further research is required to establish their risks and effectiveness while the ethical aspects associated with these strategies also need to be discussed. Despite the fact that these experimental procedures are still under development, they might provide safe fertility restoration options for oncological patients in the future.
- Published
- 2022
24. Early pregnancy loss: medical management with Mifepristone
- Author
-
Braat, D.D.M., Vandenbussche, F.P.H.A., Snijders, M.P., Coppus, S.F.P.J., Hamel, C.C., Braat, D.D.M., Vandenbussche, F.P.H.A., Snijders, M.P., Coppus, S.F.P.J., and Hamel, C.C.
- Abstract
Radboud University, 09 september 2022, Promotores : Braat, D.D.M., Vandenbussche, F.P.H.A. Co-promotores : Snijders, M.P., Coppus, S.F.P.J., Contains fulltext : 252876.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
25. Male or female sterilization - the decision making process: Counselling and regret
- Author
-
Siemons, Sara E., Vleugels, M.P.H., Balken, Michael R. van, Braat, D.D.M., Nieboer, T.E., Siemons, Sara E., Vleugels, M.P.H., Balken, Michael R. van, Braat, D.D.M., and Nieboer, T.E.
- Abstract
Contains fulltext : 282216.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
26. Women's preferences concerning IVF treatment: a discrete choice experiment with particular focus on embryo transfer policy
- Author
-
Cornelisse, S., Vos, M.S., Groenewoud, H., Mastenbroek, S., Ramos, L., Braat, D.D.M., Stalmeier, P.F.M., Fleischer, K., Cornelisse, S., Vos, M.S., Groenewoud, H., Mastenbroek, S., Ramos, L., Braat, D.D.M., Stalmeier, P.F.M., and Fleischer, K.
- Abstract
Contains fulltext : 253406.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
27. Why Turner patients with 45, X monosomy should not be excluded from fertility preservation services
- Author
-
Schleedoorn, M.J., Fleischer, K., Braat, D.D.M., Oerlemans, A.J.M., Velden, A.A.E.M. van der, Peek, R., Schleedoorn, M.J., Fleischer, K., Braat, D.D.M., Oerlemans, A.J.M., Velden, A.A.E.M. van der, and Peek, R.
- Abstract
Contains fulltext : 282832.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
28. The Tell me tool: The development and feasibility of a tool for person-centred infertility care
- Author
-
Verkerk, E.W., Rake, E.A., Braat, D.D.M., Nelen, W.L.D.M., Aarts, J.W.M., Kremer, J.A., Verkerk, E.W., Rake, E.A., Braat, D.D.M., Nelen, W.L.D.M., Aarts, J.W.M., and Kremer, J.A.
- Abstract
Contains fulltext : 251840.pdf (Publisher’s version ) (Open Access), BACKGROUND: An important-and often missing-element of person-centred care is the inclusion of individual patients' values and preferences. This is challenging but especially important for high-burden fertility treatments. We describe the development of a clinical tool that aims to facilitate the delivery of person-centred fertility care by giving insight into the patients' values and preferences. METHODS: We developed the Tell me tool following the three principles of user-centred design: (1) early and continual focus on users; (2) iterative design; (3) measurement of user behaviour. Accordingly, our methods consisted of three phases: (1) conducting semi-structured interviews with 18 couples undergoing fertility treatment, followed by a consensus meeting with relevant stakeholders; (2) performing seven iterative improvement rounds; (3) testing the feasibility of the tool in 10 couples. RESULTS: The Tell me tool consists of a ranking assignment of 13 themes and two open-ended questions. These themes relate to the couples' wellbeing and experience of the treatment, such as mental health and shared decision making. The open-ended questions ask them to write down what matters most to them. The field test showed variation between the individual patients' answers. The tool proved to highlight what is important to the individual patient and gives insight into patients' personal contexts. CONCLUSIONS: We developed a tool that gives insight into the values and preferences of the individual patient. The tool seems feasible for facilitating person-centred fertility care. PATIENT OR PUBLIC CONTRIBUTION: The tool was developed with a user-centred design that strongly involved patients.
- Published
- 2022
29. Exploration of fertility and early menopause related information needs and development of online information for young breast cancer survivors
- Author
-
Sparidaens, E.M., Beerendonk, C.C.M., Fleischer, K., Nelen, W.L.D.M., Braat, D.D.M., Hermens, R.P.M.G., Sparidaens, E.M., Beerendonk, C.C.M., Fleischer, K., Nelen, W.L.D.M., Braat, D.D.M., and Hermens, R.P.M.G.
- Abstract
Contains fulltext : 253058.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
30. Techniques used for IUI: is it time for a change?
- Author
-
Lemmens, L., Kos, S., Beijer, C., Braat, D.D.M., Nelen, W.L.D.M., and Wetzels, A.M.M.
- Published
- 2017
- Full Text
- View/download PDF
31. A de novo paradigm for male infertility
- Author
-
Oud M.S., Smits R.M., Smith H.E., Mastrorosa F.K., Holt G.S., Houston B.J., de Vries P.F., Alobaidi B.K.S., Batty L.E., Ismail H., Greenwood J., Sheth H., Mikulasova A., Astuti G.D.N., Gilissen C., McEleny K., Turner H., Coxhead J., Cockell S., Braat D.D.M., Fleischer K., D’Hauwers K.W.M., Schaafsma E., Carrell D.T., Hotaling J.M., Jenkins T.G., McLachlan R., Schlegel P.N., Eisenberg M.L., Sandlow J.I., Jungheim E.S., Omurtag K.R., Lopes A.M., Seixas S., Carvalho F., Fernandes S., Barros A., Gonçalves J., Caetano I., Pinto G., Correia S., Laan M., Punab M., Meyts E.R.-D., Jørgensen N., Almstrup K., Krausz C.G., Jarvi K.A., Nagirnaja L., Conrad D.F., Friedrich C., Kliesch S., Aston K.I., Riera-Escamilla A., Krausz C., Gonzaga-Jauregui C., Santibanez-Koref M., Elliott D.J., Vissers L.E.L.M., Tüttelmann F., O’Bryan M.K., Ramos L., Xavier M.J., van der Heijden G.W., Veltman J.A., and Genetics of Male Infertility Initiative (GEMINI) consortium
- Subjects
Adult ,Male ,phenotype ,Mutation, Missense ,Gene Expression ,Cell Cycle Proteins ,Whole Exome Sequencing ,loss of function mutation ,cell cycle protein ,gene expression profiling ,Humans ,genetics ,Exome ,Genetic Predisposition to Disease ,human ,tumor suppressor protein ,oligospermia ,Azoospermia ,missense mutation ,Tumor Suppressor Proteins ,RNA-Binding Proteins ,case control study ,RNA binding protein ,DNA binding protein ,RBM5 protein, human ,DNA-Binding Proteins ,Case-Control Studies ,RNA ,pathology ,mutation ,infertility ,genetic predisposition - Abstract
De novo mutations are known to play a prominent role in sporadic disorders with reduced fitness. We hypothesize that de novo mutations play an important role in severe male infertility and explain a portion of the genetic causes of this understudied disorder. To test this hypothesis, we utilize trio-based exome sequencing in a cohort of 185 infertile males and their unaffected parents. Following a systematic analysis, 29 of 145 rare (MAF < 0.1%) protein-altering de novo mutations are classified as possibly causative of the male infertility phenotype. We observed a significant enrichment of loss-of-function de novo mutations in loss-of-function-intolerant genes (p-value = 1.00 × 10-5) in infertile men compared to controls. Additionally, we detected a significant increase in predicted pathogenic de novo missense mutations affecting missense-intolerant genes (p-value = 5.01 × 10-4) in contrast to predicted benign de novo mutations. One gene we identify, RBM5, is an essential regulator of male germ cell pre-mRNA splicing and has been previously implicated in male infertility in mice. In a follow-up study, 6 rare pathogenic missense mutations affecting this gene are observed in a cohort of 2,506 infertile patients, whilst we find no such mutations in a cohort of 5,784 fertile men (p-value = 0.03). Our results provide evidence for the role of de novo mutations in severe male infertility and point to new candidate genes affecting fertility. © 2022, The Author(s).
- Published
- 2022
32. Glucose/lactate metabolism of cryopreserved intact bovine ovaries as a novel quantitative marker to assess tissue cryodamage
- Author
-
Gerritse, R., Beerendonk, C.C.M., Westphal, J.R., Bastings, L., Braat, D.D.M., and Peek, R.
- Published
- 2011
- Full Text
- View/download PDF
33. Tailored expectant management in couples with unexplained infertility does not influence their experiences with the quality of fertility care
- Author
-
Kersten, F.A.M., Hermens, R.P.G.M., Braat, D.D.M., Tepe, E., Sluijmer, A., Kuchenbecker, W.K., Van den Boogaard, N., Mol, B.W.J., Goddijn, M., Nelen, W.L.D.M., Hompes, P.G., Verhoeve, H.R., Gianotten, J., de Bruin, J.P., de Koning, C.H., Koks, C.A., Broekmans, F.J., Manger, A.P., Muijsers, G.J.J.M., Kwee, J., Scheffer, G.J., van Rijn, J.M., Pelinck, M.J., van Rooij, I.A., Hoek, A., Spinder, T., van Rumste, M.M., Boks, D., Vollebergh, J.H., Scheenjes, E., and van der Ploeg, J.M.
- Published
- 2016
- Full Text
- View/download PDF
34. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive
- Author
-
Baysal, Ö., Bastings, L., Beerendonk, C.C.M., Postma, S.A.E., IntHout, J., Verhaak, C.M., Braat, D.D.M., and Nelen, W.L.D.M.
- Published
- 2015
- Full Text
- View/download PDF
35. Melanoma risk after ovarian stimulation for in vitro fertilization
- Author
-
Spaan, M., van den Belt-Dusebout, A.W., Schaapveld, M., Mooij, T.M., Burger, C.W., van Leeuwen, F.E., Schats, R., Lambalk, C.B., Kortman, M., Laven, J.S.E., Jansen, C.A.M., Helmerhorst, F.M., Cohlen, B.J., Braat, D.D.M., Smeenk, J.M.J., Simons, A.H.M., van der Veen, F., Evers, J.L.H., and van Dop, P.A.
- Published
- 2015
- Full Text
- View/download PDF
36. A preliminary study on a new model system to evaluate tumour-detection and tumour-purging protocols in ovarian cortex tissue intended for fertility preservation
- Author
-
Peek, R., Bastings, L., Westphal, J.R., Massuger, L.F.A.G., Braat, D.D.M., and Beerendonk, C.C.M.
- Published
- 2015
- Full Text
- View/download PDF
37. Overtreatment in couples with unexplained infertility
- Author
-
Kersten, F.A.M., Hermens, R.P.G.M., Braat, D.D.M., Hoek, A., Mol, B.W.J., Goddijn, M., and Nelen, W.L.D.M.
- Published
- 2015
- Full Text
- View/download PDF
38. Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway
- Author
-
Eijkenboom, L., Mulder, C., Reijden, B.A. van der, Mello, N. van, Leersum, J. van, Koorenhof-Scheele, T., Braat, D.D.M., Beerendonk, C.C., Peek, R., Eijkenboom, L., Mulder, C., Reijden, B.A. van der, Mello, N. van, Leersum, J. van, Koorenhof-Scheele, T., Braat, D.D.M., Beerendonk, C.C., and Peek, R.
- Abstract
Contains fulltext : 238914.pdf (Publisher’s version ) (Closed access), PURPOSE: Is it possible to eliminate metastasised chronic myeloid leukaemia (CML) and acute myeloid leukaemia (AML) cells from ovarian cortex fragments by inhibition of Aurora B/C kinases (AURKB/C) without compromising ovarian tissue or follicles? METHODS: Human ovarian cortex tissue with experimentally induced tumour foci of CML, AML and primary cells of AML patients were exposed to a 24h treatment with 1 μM GSK1070916, an AURKB/C inhibitor, to eliminate malignant cells by invoking mitotic catastrophe. After treatment, the inhibitor was removed, followed by an additional culture period of 6 days to allow any remaining tumour cells to form new foci. Ovarian tissue integrity after treatment was analysed by four different assays. Appropriate controls were included in all experiments. RESULTS: Foci of metastasised CML and AML cells in ovarian cortex tissue were severely affected by a 24h ex vivo treatment with an AURKB/C inhibitor, leading to the formation of multi-nuclear syncytia and large-scale apoptosis. Ovarian tissue morphology and viability was not compromised by the treatment, as no significant difference was observed regarding the percentage of morphologically normal follicles, follicular viability, glucose uptake or in vitro growth of small follicles between ovarian cortex treated with 1 μM GSK1070916 and the control. CONCLUSION: Purging of CML/AML metastases in ovarian cortex is possible by targeting the Mitotic Catastrophe Signalling Pathway using GSK1070916 without affecting the ovarian tissue. This provides a therapeutic strategy to prevent reintroduction of leukaemia and enhances safety of autotransplantation in leukaemia patients currently considered at high risk for ovarian involvement.
- Published
- 2021
39. Assessing the use of tumor-specific DARPin-toxin fusion proteins for ex vivo purging of cancer metastases from human ovarian cortex before autotransplantation
- Author
-
Eijkenboom, L.L., Palacio-Castaneda, V., Braat, D.D.M., Beerendonk, C.C.M., Brock, R.E., Verdurmen, W.P.R., Eijkenboom, L.L., Palacio-Castaneda, V., Braat, D.D.M., Beerendonk, C.C.M., Brock, R.E., and Verdurmen, W.P.R.
- Abstract
Contains fulltext : 244765.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
40. Complete Purging of Ewing Sarcoma Metastases from Human Ovarian Cortex Tissue Fragments by Inhibiting the mTORC1 Signaling Pathway
- Author
-
Peek, R., Eijkenboom, L.L., Braat, D.D.M., Beerendonk, C.C.M., Peek, R., Eijkenboom, L.L., Braat, D.D.M., and Beerendonk, C.C.M.
- Abstract
Contains fulltext : 244576.pdf (Publisher’s version ) (Open Access), Restoration of fertility by autologous transplantation of ovarian cortex tissue in former cancer patients may lead to the reintroduction of malignancy via the graft. Pharmacological ex vivo purging of ovarian cortex fragments prior to autotransplantation may reduce the risk of reseeding the cancer. In this study we have investigated the capacity of Everolimus (EVE), an inhibitor of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, to eradicate Ewing's sarcoma (ES) from ovarian tissue by a short-term ex vivo treatment. Exposure of experimentally induced ES tumor foci in ovarian tissue to EVE for 24 h completely eliminated the malignant cells without detrimental effects on follicle morphology, survival or early folliculogenesis. This indicates that effective purging of ovarian cortex tissue from contaminating ES tumor foci is possible by short-term exposure to EVE.
- Published
- 2021
41. Determining the effectiveness of cognitive behavioural therapy in improving quality of life in patients undergoing endometriosis surgery: A study protocol for a randomised controlled trial
- Author
-
Boersen, Z., Oosterman, J.M., Hameleers, E.G., Delcliseur, H.S.M.J., Lutters, C., IJssel de Schepper, K.A., Braat, D.D.M., Verhaak, C.M., Nap, A.W., Boersen, Z., Oosterman, J.M., Hameleers, E.G., Delcliseur, H.S.M.J., Lutters, C., IJssel de Schepper, K.A., Braat, D.D.M., Verhaak, C.M., and Nap, A.W.
- Abstract
Contains fulltext : 241594.pdf (Publisher’s version ) (Open Access), Introduction: Endometriosis can cause chronic pain and subfertility thereby negatively affecting quality of life (QoL). Surgical removal of endometriosis lesions leads to improved health-related QoL, although not to the level of QoL of healthy controls. Pain intensity and cognitions regarding pain can play a crucial role in this health-related QoL following surgical treatment. Cognitive behavioural therapy (CBT) is a psychological treatment. In patients with chronic pain caused by a variety of medical conditions, CBT is effective in improving QoL. We designed a research protocol to investigate the effect of CBT on QoL in patients with endometriosis-associated chronic pain who are undergoing surgery. Methods and analysis: This is a study protocol for a randomised controlled trial in which 100 patients, undergoing endometriosis removal surgery due to endometriosis-associated chronic pain, will be randomised between post-surgery usual care with CBT and post-surgery usual care only. Participants in the CBT group will additionally receive seven sessions of CBT, focused on expectancy management, cognitions regarding pain and emotional and behavioural impact of pain. To determine the primary outcome Quality of life, both groups will complete questionnaires assessing QoL. The secondary outcomes pain intensity, pain cognitions, fatigue and perceived stress are also measured using questionnaires. Additionally, a marker for stress (cortisol extracted from a hair sample) will be assessed at T0 (baseline assessment), T1 (post-intervention; 2 weeks after completion of all CBT sessions) and T2 (follow-up; 14 weeks after T1). Statistical analysis will be performed using SPSS software. Ethics and dissemination: The study protocol has been approved by the Medical Ethical Committee of the region Arnhem-Nijmegen from the Radboud University Medical Centre on 2 September 2020. The findings of this study will be published in scientific journals and will be presented at scientific conferen
- Published
- 2021
42. Genetic and lifestyle factors affecting male infertility
- Author
-
Braat, D.D.M., Veltman, J.A., Fleischer, K., Ramos, L., Smits, R.M., Braat, D.D.M., Veltman, J.A., Fleischer, K., Ramos, L., and Smits, R.M.
- Abstract
Radboud University, 27 oktober 2021, Promotores : Braat, D.D.M., Veltman, J.A. Co-promotores : Fleischer, K., Ramos, L., Contains fulltext : 236701.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
43. Kies wijzer!
- Author
-
Braat, D.D.M. and Braat, D.D.M.
- Abstract
Rede uitgesproken bij het afscheid van het ambt van hoogleraar Obstetrie & Gynaecologie ... aan de Faculteit der Medische Wetenschappen van de Radboud Universiteit/het Radboudumc op 23 juni 2021, Contains fulltext : 235122.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
44. Why are some patients with 45,X Turner syndrome fertile? A young girl with classical 45,X Turner syndrome and a cryptic mosaicism in the ovary
- Author
-
Nadesapillai, S., Velden, A.A.E.M. van der, Smeets, D.F., Zande, G. van de, Braat, D.D.M., Fleischer, K., Peek, R., Nadesapillai, S., Velden, A.A.E.M. van der, Smeets, D.F., Zande, G. van de, Braat, D.D.M., Fleischer, K., and Peek, R.
- Abstract
Contains fulltext : 233632.pdf (Publisher’s version ) (Open Access)
- Published
- 2021
45. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology
- Author
-
Spaan, M., Belt-Dusebout, A.W. van den, Lambalk, C.B., Boven, H.H. van, Schats, R., Kortman, M., Broekmans, F.J., Laven, J. S. E., Santbrink, E.J. van, Braat, D.D.M., Westerlaken, L.A.J. van, Cohlen, B.J., Cantineau, A.E.P., Smeenk, J.M., Rumste, M.M. van, Goddijn, M., Golde, R.J.T. van, Meeuwissen, P.A.M., Hamilton, C., Ouwens, G.M., Gerritsma, M.A., Schaapveld, M., Burger, C.W., Leeuwen, F.E. van, Spaan, M., Belt-Dusebout, A.W. van den, Lambalk, C.B., Boven, H.H. van, Schats, R., Kortman, M., Broekmans, F.J., Laven, J. S. E., Santbrink, E.J. van, Braat, D.D.M., Westerlaken, L.A.J. van, Cohlen, B.J., Cantineau, A.E.P., Smeenk, J.M., Rumste, M.M. van, Goddijn, M., Golde, R.J.T. van, Meeuwissen, P.A.M., Hamilton, C., Ouwens, G.M., Gerritsma, M.A., Schaapveld, M., Burger, C.W., and Leeuwen, F.E. van
- Abstract
Item does not contain fulltext, BACKGROUND: Long-term effects of assisted reproductive technology (ART) on ovarian tumor risk are unknown. METHODS: This nationwide cohort study comprises 30 625 women who received ovarian stimulation for ART in 1983-2000 and 9988 subfertile women not treated with ART. Incident invasive and borderline ovarian tumors were ascertained through linkage with the Netherlands Cancer Registry and the Dutch Pathology Registry until July 2018. Ovarian tumor risk in ART-treated women was compared with risks in the general population and the subfertile non-ART group. Statistical tests were 2-sided. RESULTS: After a median follow-up of 24 years, 158 invasive and 100 borderline ovarian tumors were observed. Ovarian cancer risk in the ART group was increased compared with the general population (standardized incidence ratio [SIR] = 1.43, 95% confidence interval [CI] = 1.18 to 1.71) but not when compared with the non-ART group (age- and parity-adjusted hazard ratio [HR] = 1.02, 95% CI = 0.70 to 1.50). Risk decreased with higher parity and with a larger number of successful ART cycles (resulting in childbirth, Ptrend = .001) but was not associated with the number of unsuccessful ART cycles. Borderline ovarian tumor risk was increased in ART-treated women compared with the general population (SIR = 2.20, 95% CI = 1.66 to 2.86) and with non-ART women (HR = 1.84, 95% CI = 1.08 to 3.14). Risk did not increase with more ART cycles or longer follow-up time. CONCLUSIONS: Increased ovarian cancer risk in ART-treated women compared with the general population is likely explained by nulliparity rather than ART treatment. The increased risk of borderline ovarian tumors after ART must be interpreted with caution because no dose-response relationship was observed.
- Published
- 2021
46. Home-based postpartum care. Flexibility as an innovative approach to more client-centred care
- Author
-
Kremer, J.A.M., Braat, D.D.M., Duijnhoven, N.T.L. van, Dedding, Christine W.M., Lambermon, F.J., Kremer, J.A.M., Braat, D.D.M., Duijnhoven, N.T.L. van, Dedding, Christine W.M., and Lambermon, F.J.
- Abstract
Radboud University, 10 november 2021, Promotores : Kremer, J.A.M., Braat, D.D.M. Co-promotores : Duijnhoven, N.T.L. van, Dedding, Christine W.M., Contains fulltext : 239214.pdf (Publisher’s version ) (Closed access)
- Published
- 2021
47. Effect of needle diameter on pain during oocyte retrieval-a randomized controlled trial
- Author
-
Buisman, E.T.I.A., Bruin, Jan Peter de, Braat, D.D.M., Steeg, Jan Willem van der, Buisman, E.T.I.A., Bruin, Jan Peter de, Braat, D.D.M., and Steeg, Jan Willem van der
- Abstract
Contains fulltext : 233492.pdf (Publisher’s version ) (Closed access)
- Published
- 2021
48. Strengths and weaknesses in the diagnostic process of endometriosis from the patients' perspective: a focus group study
- Author
-
Zanden, M. van der, Kok, L.M. de, Nelen, W.L.D.M., Braat, D.D.M., Nap, A.W., Zanden, M. van der, Kok, L.M. de, Nelen, W.L.D.M., Braat, D.D.M., and Nap, A.W.
- Abstract
Item does not contain fulltext
- Published
- 2021
49. Development and testing of a tailored online fertility preservation decision aid for female cancer patients
- Author
-
Berg, M. van den, Meij, E. van der, Bos, A.M., Boshuizen, M.C.S., Determann, D., Eekeren, R. van, Lok, C. A. R., Schaake, E.E., Witteveen, P.O., Wondergem, M.J., Braat, D.D.M., Beerendonk, C.C.M., Hermens, R.P., Berg, M. van den, Meij, E. van der, Bos, A.M., Boshuizen, M.C.S., Determann, D., Eekeren, R. van, Lok, C. A. R., Schaake, E.E., Witteveen, P.O., Wondergem, M.J., Braat, D.D.M., Beerendonk, C.C.M., and Hermens, R.P.
- Abstract
Contains fulltext : 232410.pdf (Publisher’s version ) (Open Access), BACKGROUND: Decision making regarding future fertility can be very difficult for female cancer patients. To support patients in decision making, fertility preservation decision aids (DAs) are being developed. However, to make a well-informed decision, patients need personalized information tailored to their cancer type and treatment. Tailored cancer-specific DAs are not available yet. METHODS: Our DA was systematically developed by a multidisciplinary steering group (n = 21) in an iterative process of draft development, three rounds of alpha testing, and revisions. The drafts were based on current guidelines, literature, and patients' and professionals' needs. RESULTS: In total, 24 cancer-specific DAs were developed. In alpha testing, cancer survivors and professionals considered the DA very helpful in decision making, and scored an 8.5 (scale 1-10). In particular, the cancer-specific information and the tool for recognizing personal values were of great value. Revisions were made to increase readability, personalization, usability, and be more careful in giving any false hope. CONCLUSIONS: A fertility preservation DA containing cancer-specific information is important in the daily care of female cancer patients and should be broadly available. Our final Dutch version is highly appraised, valid, and usable in decision making. After evaluating its effectiveness with newly diagnosed patients, the DA can be translated and adjusted according to (inter)national guidelines.
- Published
- 2021
50. Patients' perspective on cognitive behavioural therapy after surgical treatment of endometriosis: A qualitative study
- Author
-
Boersen, Z., Kok, L.M. de, Zanden, M. van der, Braat, D.D.M., Oosterman, J.M., Nap, A.W., Boersen, Z., Kok, L.M. de, Zanden, M. van der, Braat, D.D.M., Oosterman, J.M., and Nap, A.W.
- Abstract
Item does not contain fulltext, Research question: Would adding cognitive behavioural therapy (CBT) to the treatment of endometriosis improve the quality of life of patients suffering from endometriosis-associated pain? The aim of this study was to identify if patients believed CBT should be added to endometriosis treatment and which form of CBT they would prefer: face-to-face individual or group, or web-based individual, sessions. Design: Between November 2019 and January 2020, semi-structured focus groups were conducted using an interview guide to ensure all topics were discussed. Data collection was continued until saturation was obtained. The focus groups were transcribed word for word and openly encoded. Finally, themes were formulated. Results: All participating women believed CBT should be offered to patients undergoing endometriosis surgery. They believed it could be an asset to improve quality of life. Participants preferred either in-person individual or group therapy. They stressed the importance of being offered a custom-made treatment plan, individually tailored to the different needs of different patients. Conclusion: This study has shown that patients with endometriosis believe that CBT should be added to the standard treatment regimen of endometriosis in either group or individual face-to-face sessions, because they expect that CBT will improve their quality of life after surgery.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.